LivaNova PLC - Ordinary Shares (LIVN) Social Stream



LivaNova PLC - Ordinary Shares (LIVN): $55.69

-0.47 (-0.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LIVANOVA PLC (LIVN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering LIVANOVA PLC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-06 6 $120 $84 $103.666 $52.93 95.85%
2022-02-24 6 $120 $96 $105.5 $52.93 99.32%
2022-05-03 6 $120 $95 $104 $52.93 96.49%
2022-05-05 5 $120 $95 $103.285 $52.93 95.14%
2022-08-04 6 $105 $88 $96.571 $52.93 82.45%
2022-08-16 6 $100 $73 $92 $52.93 73.81%
2022-10-06 6 $100 $70 $88 $52.93 66.26%
2022-10-11 6 $96 $70 $85.142 $52.93 60.86%
2022-11-20 6 $96 $70 $82.142 $52.93 55.19%
2022-11-23 6 $96 $63 $80.714 $52.93 52.49%

The Trend in the Analyst Price Target


LIVN's average price target has moved down $14.46 over the prior 17 months.

Over the past 51 weeks, LIVN's average upside potential has been 47.86%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-24 6 120 84 102.428 77.74 31.76%
2022-04-06 6 120 95 104.000 83.18 25.03%
2022-05-05 5 120 95 103.285 65.38 57.98%
2022-11-03 6 96 70 82.142 47.81 71.81%
2022-11-23 6 96 63 80.714 53.72 50.25%

LIVN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 5 1 0 0 0 6

The Trend in the Broker Recommendations


Over the past 16 months, LIVN's average broker recommendation rating improved by 0.83.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LIVN as an investment opportunity.

  • LIVANOVA PLC's average analyst price target is higher than 1159.89% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, LIVANOVA PLC's variance in analysts' estimates is lower than -275.93% of them.
  • LIVN has a higher upside potential (average analyst target price relative to current price) than 1039.5% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, LIVANOVA PLC's number of analysts covering the stock is greater than 615.01% of them.

Stocks similar to LIVANOVA PLC in the Medical Equipment industry regarding analyst recommendations and price targets are CNMD, SDC, and INGN.

Is LIVN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7003 seconds.